PCSK9
前蛋白转化酶
可欣
低密度脂蛋白受体
前蛋白转化酶类
枯草杆菌素
临床试验
药理学
化学
胆固醇
医学
脂蛋白
生物化学
内科学
酶
作者
Enrico M. A. Fassi,Andrea Citarella,Marco Albani,Erica Ginevra Milano,Laura Legnani,Carmen Lammi,Alessandra Silvani,Giovanni Grazioso
标识
DOI：10.1080/13543776.2024.2340569
摘要
Proprotein convertase subtilisin/kexin 9 (PCSK9) plays a crucial role in breaking down the hepatic low-density lipoprotein receptor (LDLR), thereby influencing the levels of circulating low-density lipoprotein cholesterol (LDL-C). Consequently, inhibiting PCSK9 through suitable ligands has been established as a validated therapeutic strategy for combating hypercholesterolemia and cardiovascular diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI
JY
寻道图强
lin
Cloud
CipherSage
穆紫
美好乐松
凤凰
星辰大海
温暖的盼山
hzc
黑白
脑洞疼
Simon
结实的寄柔
可爱的函函
科目三
Owen
只谈风月
霉小欧
皖公网安备34019202002308
